Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-04

Clinical Trial Update: Study of Teriparatide in Stress Fracture Healing [Phase 3]

View source ↗

Summary

Phase 3 trial update for teriparatide in stress fracture healing is ongoing with unclear status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriparatide (Teriparatide)

Snippet

Sponsor: University of East Anglia | Conditions: Stress Fracture, Parathyroid Hormone | Phase 3 | Status: UNKNOWN